Concord Biotech Ltd. - Research Center
543960 CONCORDBIO Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Dec' 23 | Sep' 23 | Jun' 23 | Dec' 22 | Sep' 22 | |
|---|---|---|---|---|---|
| Sales | 240.80 | 262.35 | 194.83 | 240.68 | 158.90 |
| Operating profit | 105.93 | 119.19 | 72.15 | 111.68 | 37.92 |
| Interest | 0.50 | 0.84 | 0.75 | 0.91 | 1.11 |
| Gross profit | 113.62 | 126.47 | 78.05 | 120.02 | 42.84 |
| EPS (Rs) | 7.13 | 8.08 | 4.63 | 7.56 | 2.15 |
Quarterly
results in details
| Dec' 23 | Sep' 23 | Jun' 23 | Dec' 22 | Sep' 22 | |
|---|---|---|---|---|---|
| Other income | 8.19 | 8.13 | 6.65 | 9.25 | 6.03 |
| Stock adjustment | -23.52 | 0.39 | -10.67 | -1.47 | -7.68 |
| Raw material | 47.39 | 42.00 | 39.48 | 43.36 | 34.94 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 30.67 | 30.17 | 28.25 | 27.54 | 28.88 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 80.33 | 70.60 | 65.62 | 59.57 | 64.84 |
| Provisions made | - | - | - | - | - |
| Depreciation | 13.54 | 13.30 | 13.04 | 13.77 | 12.51 |
| Taxation | 25.53 | 28.68 | 16.54 | 27.17 | 7.88 |
| Net profit / loss | 74.55 | 84.49 | 48.47 | 79.08 | 22.44 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 10.46 | 10.46 | 10.46 | 10.46 | 10.46 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 43.99 | 45.43 | 37.03 | 46.40 | 23.86 |
| GPM (%) | 45.63 | 46.76 | 38.74 | 48.02 | 25.97 |
| NPM (%) | 29.94 | 31.24 | 24.06 | 31.64 | 13.61 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis